This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer
Journal of Hematology & Oncology Open Access 03 July 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Dimopoulos MA, Panayiotidis P, Moulopoulos LA, Sfikakis P, Dalakas M . Waldenstrom's macroglobulinemia: clinical features, complications, and management. J Clin Oncol 2000; 18: 214–216.
Chang H, Bouman D, Boerkoel CF, Stewart AK, Squire JA . Frequent monoallelic loss of D13S319 in multiple myeloma patients shown by interphase fluorescence in situ hybridization. Leukemia 1999; 13: 105–109.
Fonseca R, Blood E, Rue M, Harrington D, Oken MM, Kyle RA et al. Clinical biologic implications of recurrent genomic aberrations in myeloma. Blood 2003; 101: 4569–4575.
Chang H, Sloan S, Li D, Zhuang L, Yi QL, Chen CI et al. The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplant. Br J Haematol 2004; 125: 64–68.
Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000; 343: 1910–1916.
Schop RF, Kuehl WM, Van Wier SA, Ahmann GJ, Price-Troska T, Bailey RJ et al. Waldenstrom macrogobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletions. Blood 2002; 100: 2996–3001.
Willis TG, Dyer MJS . The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies. Blood 2002; 96: 808–822.
Schop RF, Jalal SM, Van Wier SA, Ahmann GJ, Bailey RJ, Kyle RA et al. Deletions of 17p13.1 and 13q14 are uncommon in Waldenstrom macroglobulinemia clonal cells and mostly seen at the time of disease progression. Cancer Gene Cytogenet 2002; 132: 55–60.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chang, H., Samiee, S., Li, D. et al. Analysis of IgH translocations, chromosome 13q14 and 17p13.1(p53) deletions by fluorescence in situ hybridization in Waldenstrom's macroglobulinemia: a single center study of 22 cases. Leukemia 18, 1160–1162 (2004). https://doi.org/10.1038/sj.leu.2403369
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403369
This article is cited by
-
MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer
Journal of Hematology & Oncology (2017)
-
Genetic Factors and Pathogenesis of Waldenström’s Macroglobulinemia
Current Oncology Reports (2013)
-
Stem cell transplant for Waldenström macroglobulinemia: an underutilized technique
Bone Marrow Transplantation (2012)